Howard Hughes Medical Institute’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18
Closed -$4.52K 290
2025
Q4
$4.52K Hold
18
﹤0.01% 362
2025
Q3
$5.17K Hold
18
﹤0.01% 331
2025
Q2
$4.72K Buy
+18
New +$4.38K ﹤0.01% 341
2016
Q3
Sell
-1,198
Closed -$134K 163
2016
Q2
$134K Sell
1,198
-4,047
-77% -$436K 0.05% 126
2016
Q1
$528K Sell
5,245
-2,402
-31% -$230K 0.12% 80
2015
Q4
$812K Buy
+7,647
New +$789K 0.12% 79

Other funds holding LH

Howard Hughes Medical Institute's LH Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Labcorp (LH) in Q1 2026, closing a stake of 18 shares — an estimated $4.52K sold.

Howard Hughes Medical Institute first reported a position in LH in Q4 2015 and held it in 6 quarters. The position peaked at $812K in Q4 2015. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 18 Labcorp shares in Q1 2026, an estimated $4.52K.
  • Howard Hughes Medical Institute first reported a position in Labcorp in Q4 2015 and held it in 6 quarters.
  • Howard Hughes Medical Institute's Labcorp position peaked at $812K in Q4 2015.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.